Biotech News

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Achieve Life Sciences (ACHV)Achieve Life Sciences2026-06-25 13:46 ESTFDA / regulatory

ACHV (ACHV) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is achv.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

ACHVAchieve Life Sciences2026-06-25 13:46 EST

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Achieve Life Sciences

Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States